ALPS Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-95,276
| Closed | -$1.92M | – | 1004 |
|
|
2021
Q3 | $1.92M | Buy |
95,276
+86,586
| +996% | +$1.75M | 0.02% | 325 |
|
|
2021
Q2 | $324K | Sell |
8,690
-129,384
| -94% | -$4.82M | ﹤0.01% | 785 |
|
|
2021
Q1 | $3.53M | Buy |
138,074
+3,489
| +3% | +$89.2K | 0.03% | 194 |
|
|
2020
Q4 | $2.97M | Buy |
134,585
+39,628
| +42% | +$873K | 0.03% | 216 |
|
|
2020
Q3 | $1.71M | Sell |
94,957
-5,880
| -6% | -$106K | 0.03% | 255 |
|
|
2020
Q2 | $2.56M | Sell |
100,837
-23,574
| -19% | -$599K | 0.03% | 210 |
|
|
2020
Q1 | $2.29M | Sell |
124,411
-13,508
| -10% | -$248K | 0.04% | 204 |
|
|
2019
Q4 | $3.04M | Buy |
137,919
+1,615
| +1% | +$35.6K | 0.02% | 192 |
|
|
2019
Q3 | $1.96M | Sell |
136,304
-6,696
| -5% | -$96.1K | 0.02% | 212 |
|
|
2019
Q2 | $2.25M | Buy |
+143,000
| New | +$2.25M | 0.02% | 214 |
|